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Intestinal Transplantation at the University of Pittsburgh 
S. Todo, A. Tzakis, J. Reyes, K. Abu-Elmagd. H. Furukawa. B. Nour, Z. Kadry. J. Fung. and T.E. Starzt 
FROM May 1990 to August 1993.59 patients received intestinal transplantation under FK 506 immunosup-
pression at the University of Pittsburgh. Preliminary data 
from our series have been reported before. l~ 
CASE MATERIAL 
Of the 59 recipients. 32 were children with a mean age of 3.8 :t: 3.7 
years. and 27 were adults with a mean age of 33.4 :t 9.8 years. 
There were 3 types of intestinal transplantation. An isolated graft 
was given to 22 patients who had irreversible intestinal failure but 
normal liver function. Combined intestine and liver grafts were 
transplanted to 26 patients who had failure of both organs. Eleven 
patients who had thrombosis in the 2 central arteries or in the 
mesenteric venous system. or abnormality of the entire gastroin-
testinal tract. received multivisceral grafts. There were an addi-
tional2 adult patients who died on the table from massive bleeding 
during dissection of the naUve organs for multi visceral transplan-
tation. 
The operative procedures for organ procurement and transplan-
tation. as well as postoperative management. were described 
previously 1-6 and in this issue. 7- 9 
RESULTS 
Forty-two patients are currently alive with a minimum 
follOW-lip of 2 months. The patient survival was 84.6% at 
3 months, 80.6% at 6 months, 77.6% at 12 months, and 
71.4% at 24 months. Causes of the 17 mortalities were 
sepsis from graft rejection (n = 9). technical failure (n = 3). 
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other (n = 3). Two patients had evidence of graft-versus-
host disease at autopsy. 
Twelve grafts were removed at various postoperative 
periods due to acute rejection (n = 7). chronic rejection 
(n = 2). or other reasons (n = 3). of which four underwent 
retransplantation. Graft survival was 73.9% at 3 months. 
72.0% at 6 months. 67.1% at 12 months. and 53.1% at 24 
months. There were no differences in patient and graft 
survival between adult and pediatric recipients. 
Of the 22 isolated intestinal recipients. 5 died and 8 
required graft removal. Patient and graft survival rates 
were 95.5% and 73.9% at 3 months. 89.1% and 68.6% at 6 
months. 89.1% and 62.9% at 12 months. and 79.2% and 
41.3% at 24 months. respectively (Fig I). Of the 26 
combined intestine and liver recipients. 10 died and 3 
required graft removal. Patient and graft survival rates for 
this group were 76.9% and 70.4% at 3 months. 73.1% and 
70.4% at 6 months. 67.9% and 65.3% at 12 months. and 
62.6% and 54.8% at 24 months, respectively. Of the II 
multivisceral patients. 2 died and 1 required removal of the 
pancreatic graft for hemorrhagic pancreatitis. The patient 
and graft survival rate was 81.8% for these patients. 
From the Pittsburgh Transplantation Institute. University of Pitts-
burgh Medical Center. Pittsburgh, Pennsylvania. 
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l+---~---r~~--~ l+----r--~~~~--~ Fig 1, Patient and graft survival 
after intestinal transplantation. 
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Of the 42 recIpIents who are currently alive. 34 are 
completely free from total parenteral nutrition (TPN) on an 
unrestricted oral diet. 4 require partial TPN support. and 4 
resumed TPN after graft removal. 
SUMMARY 
Our experience with clinical intestinal transplantation un-
der FK 506 immunosuppression showed that 50% of the 
recipients were able to be independent from TPN after 
transplantation. but 10% require partial TPN with func-
tioning grafts. 10% needed total TPN after graft removal. 
and 30% of the recipients died postoperatively. mostly 
from sepsis due to severe graft rejection. For further 
improvement in patient survival and in the quality of life 
for patients after intestinal transplantation. it is mandatory 
to establish a new strategy for treatment and prevention of 
graft rejection and systemic infection. 
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